TP53 and neoplasm: This engineered cyclotide showed high cytotoxicity to several wild-type p53 cancer cell lines and was able to activate the p53 tumor suppressor pathway both in vitro and in vivo using an animal model of human colorectal carcinoma (Figure 5) [5].